Life Sciences Year End Review – Implications of 2023 Regulatory and Enforcement Developments (On-Demand Webinar)
Closed captions are available.
Overview: As you begin planning for 2024, this presentation is intended to provide you with a basic understanding of important legal developments in the life sciences industry that may affect your operations, compliance work plans, and general planning for the upcoming year.
The presenters discuss the regulatory and enforcement developments in each area of life sciences, including pharmaceuticals, medical devices, and clinical laboratories, that took place in 2023. The presenters also touch on significant proposals, such as the FDA's proposal to regulate laboratory-developed tests, and recent FDA and FTC guidance on direct-to-consumer advertising, which can have an effect on promotional activities for life science companies. The webinar also provides an overview of changes in the anti-trust enforcement environment that may impact life sciences companies.
- Enhance the understanding of life science professionals regarding the latest regulatory developments affecting their businesses, fostering a collaborative learning environment to navigate evolving compliance landscapes.
- Keep life science companies informed about recent enforcement actions, aiding proactive management of potential impacts on business and compliance.
- Promote awareness and understanding among life science professionals of recent antitrust developments, encouraging a commitment to fair competition and ethical business practices for sustainable and inclusive industry growth.
Danielle Sloane, Member, Bass, Berry and Sims
Daryl Daly, Counsel, Bristol Myers Squibb
Seth Mailhot, Partner, Husch Blackwell
Bevin Newman, Partner, Sheppard Mullin
CLE: AHLA’s webinars are pre-approved for CLE credit in the following states: AL, AR, CA, GA, IL, IN, KS, ME, MI, MS, NC, NE, NJ, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WI, and WV. Please refer to the Distance Learning CLE State Chart on our Continuing Education Page to review the reporting procedure in these and other states.
CPE: AHLA is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Nashville, TN 37219-2417. Website: www.nasba.org. For further information, please visit our Continuing Education Page.
AHLA is seeking CPE credits for live and on demand webinars. The maximum number of credits available is 1.80.
The Compliance Certification Board (CCB)® has approved this event for up to 1.8 Non-live CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor.
Also available from AHLA: Market Access, Pricing, and Reimbursement of Drugs and Devices: Legal Principles and Practice